Validated by Science. Trusted by Clinicians.
MyMycoLab’s blood serum mycotoxin antibody testing is backed by over 20 years of peer-reviewed research, individually validated analytes, and the trust of more than 2,500 practitioners nationwide.
Accuracy in mycotoxin testing is not just about detecting a toxin it’s about producing results that clinicians can act on with confidence. That requires a validated methodology, a controlled laboratory environment, and a body of published research confirming that the test measures what it claims to measure.
MyMycoLab’s blood serum antibody testing meets all three criteria. The methodology, detecting IgG and IgE antibodies to specific mycotoxins in blood serum, has been used in both clinical practice and published research for over two decades. Each of the 14 analytes on the panel is individually validated for accuracy. And the results are produced in a certified high-complexity laboratory where every sample goes through a multi-step quality review before reporting.
This is not a consumer wellness screening. It is high-complexity diagnostic testing built to the standards that clinicians and patients depend on.
98%
Sensitivity and Specificity
Our serum antibody methodology achieves 98% sensitivity (the ability to correctly identify true positives) and 98% specificity (the ability to correctly rule out false positives).
14/28
Mycotoxins Tested / Individual Results
Each mycotoxin is tested separately for both IgG and IgE antibodies. Every analyte is individually validated for accuracy, not batch-tested or grouped.
20+
Years of Published Research
The blood serum antibody methodology used by MyMycoLab has been validated in peer-reviewed medical journals spanning over two decades of clinical research.
2500+
Practitioners
Healthcare providers across the country have placed orders through MyMycoLab . A trust earned through consistent, reliable results and published science.
● Published Research
Backed by Peer-Reviewed Science
MyMycoLab’s blood serum antibody methodology is not based on proprietary claims, it is grounded in published, peer-reviewed research conducted over more than two decades. Below are four key studies that form the scientific foundation of our testing.
Study 1:
Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings
Vojdani A, Thrasher JD, Madison RA, et al. Arch Environ Health. 2003;58(7):421-432.
Demonstrated that individuals exposed to molds in water-damaged buildings developed elevated IgG and IgE antibodies to specific mycotoxins. Establishing blood serum antibody detection as a valid method for confirming environmental mycotoxin exposure.
Study 2:
Detection of Trichothecene Mycotoxins in Sera from Individuals Exposed to Stachybotrys Chartarum in Indoor Environments
Brasel TL, Campbell AW, Demers RE, et al. Arch Environ Health. 2004;59(6):317-323.
Detected trichothecene mycotoxins in the blood serum of 23 out of 44 individuals living in Stachybotrys-contaminated buildings, compared to only 1 out of 26 from uncontaminated buildings. Among the first studies to directly demonstrate that indoor mold exposure produces measurable toxin levels in human blood.
Study 3:
Antibodies Against Molds and Mycotoxins Following Exposure to Toxigenic Fungi in a Water-Damaged Building
Vojdani A, Campbell AW, Kashanian A, et al. Arch Environ Health. 2003;58(6):324-336.
Confirmed that occupants of a water-damaged building developed significant antibody responses to multiple mycotoxins. Further validating blood serum antibody testing as a diagnostic tool for environmental mold exposure.
Study 4:
Mold and Mycotoxins: Effects on Neurological and Immune Systems in Humans
Campbell AW, Thrasher JD, Gray MR, Vojdani A. Adv Appl Microbiol. 2004;55:375-406.
A comprehensive review of how mold and mycotoxins affect the neurological and immune systems, including the role of blood serum antibody testing in clinical diagnosis. Cited extensively in subsequent mycotoxin research.
These studies represent a fraction of the published research supporting blood serum mycotoxin antibody testing. Dr. Andrew W. Campbell, MyMycoLab’s Medical Advisor, has authored or co-authored over 100 peer-reviewed papers on mold, mycotoxins, and their effects on human health.